Ind-Swift Laboratories Limited

NSE: INDSWFTLAB · Unclassified

₹348.20-2.40%06 Nov 2026

Check figures: unusual quarterly results in SEP '26 (₹34.22 cr vs a typical ₹0.41 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about Ind-Swift Laboratories Limited — computed from its filings, no language model

Market cap₹3,028 cr

Current price₹348.20

High / Low₹413 / ₹88

P/E69.2

P/B2.05

Book value₹169.5

ROE3.0%

ROCE7.0%

Debt / equity0.01

Dividend yield—

EPS (TTM)₹5.03

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY20	FY22	FY23	FY24	FY25	FY26
Revenue	780	1,039	1,207	1,281	562	641
EBITDA	144	196	229	254	-19	45
Operating margin	18.5%	18.9%	19.0%	19.8%	-3.5%	7.0%
Interest	107	96	92	51	3	1
Depreciation	90	131	57	53	24	31
Profit before tax	-20	13	87	582	258	49
Tax	1	15	39	151	7	8
Net profit	-21	-2	0	0	0	0
EPS ₹	-4.28	-0.36	8.06	71.24	37.25	4.95
Operating cash flow	—	150	195	-181	-25	-63
Capex	—	18	13	45	64	88
Dividend paid	—	0	0	0	0	0
Total assets	—	—	1,824	1,165	1,438	1,673
Equity	—	—	682	931	1,173	1,384

Quarterly performance

last 29 quarters · ₹ crore

showing latest 8 of 29 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	188	192	204	192	210	228	226	250	236	247	307	280	310	313	304	310	290	288	393	33	12	9	138	153	153	151	170	191	240
Operating profit	32	27	35	36	43	49	48	51	56	52	37	53	59	54	65	60	66	51	-37	-10	-12	-15	-9	4	1	4	21	33	45
Operating margin	16.8%	14.2%	17.1%	18.7%	20.6%	21.6%	21.4%	20.5%	23.8%	21.2%	12.0%	18.9%	18.9%	17.2%	21.3%	19.4%	22.7%	17.8%	-9.5%	-29.4%	-98.6%	-167.8%	-6.7%	2.4%	1.0%	2.8%	12.1%	17.5%	18.9%
Other income	5	7	6	12	6	5	9	6	7	8	21	7	8	8	10	6	7	7	25	11	13	14	4	15	18	28	2	8	8
Interest	28	25	27	21	25	25	26	24	24	24	23	24	24	22	22	20	21	21	-11	0	0	0	-27	1	2	1	-2	1	1
Depreciation	23	23	23	22	20	20	20	14	14	21	82	16	16	15	9	14	13	14	13	0	0	0	7	7	7	9	8	8	8
Profit before tax	-14	-14	-9	4	5	10	12	19	25	16	-47	20	26	24	17	32	39	24	373	1	1	-1	230	10	10	16	12	33	43
Tax	0	0	0	1	0	0	0	0	1	-0	14	0	1	-3	41	6	7	4	134	-0	0	-1	8	2	2	4	-3	8	9
Net profit	0	0	-9	3	5	10	12	0	24	16	-61	20	25	28	0	0	0	0	0	0	0	0	0	0	8	10	0	0	34
EPS ₹	-2.91	-3.04	-1.90	0.61	0.77	1.68	1.95	3.18	4.14	2.71	-10.40	3.36	4.29	4.65	-4.08	2.92	5.36	3.29	40.42	0.16	0.07	0.00	32.96	1.28	1.00	1.17	1.81	2.84	3.94
Revenue YoY	—	—	—	—	12.1%	19.2%	11.1%	18.8%	3.2%	9.0%	—	12.2%	31.6%	26.8%	-0.8%	10.8%	-6.6%	-8.1%	29.3%	-89.3%	-95.9%	-97.0%	-64.9%	360.4%	1176.3%	1641.9%	22.8%	25.4%	57.5%
Profit YoY	—	—	—	—	—	—	—	-100.0%	146.7%	38.8%	—	—	3.6%	71.6%	—	-100.0%	-100.0%	-100.0%	—	—	—	—	—	—	1848.8%	—	—	—	328.3%

Earlier results (standalone, Sep '07 – Mar '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Ind-Swift Laboratories Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	588	784	1,028	1,352	1,101	954	668	653	696	731	724
Operating profit	130	136	177	207	74	39	111	129	123	183	135
Operating margin	22.1%	17.4%	17.2%	15.3%	6.7%	4.1%	16.7%	19.7%	17.7%	25.1%	18.7%
Other income	—	—	—	—	—	—	—	—	—	18	37
Interest	52	51	57	79	105	120	119	108	88	85	83
Depreciation	27	37	39	40	54	66	84	85	88	87	104
Profit before tax	49	55	85	83	-120	-143	-143	-83	-56	29	68
Tax	9	-3	-3	-3	-1	-20	-24	-24	-16	11	20
Net profit	40	58	88	86	-119	-123	-119	-59	-40	18	48

Quarters

showing latest 8 of 47 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†
Revenue	109	114	123	140	147	153	148	170	196	217	200	200	213	310	305	279	354	359	361	305	336	235	225	253	238	249	214	189	162	159	158	173	164	154	161	179	170	175	172	164	185	166	217	179	158	196	192
Operating profit	17	19	25	27	30	29	44	28	36	32	40	42	39	52	43	53	59	64	31	-10	30	31	22	34	39	34	-69	29	29	33	20	31	31	28	38	30	32	33	29	16	30	34	105	30	29	37	40
Operating margin	16.0%	16.3%	20.7%	19.6%	20.1%	19.0%	29.6%	16.6%	18.3%	14.7%	20.1%	20.8%	18.5%	16.8%	14.2%	19.1%	16.6%	17.8%	8.6%	-3.1%	9.0%	13.3%	9.9%	13.4%	16.6%	13.8%	-32.1%	15.5%	17.7%	20.8%	12.9%	17.8%	19.2%	18.2%	23.8%	16.7%	18.5%	18.9%	16.8%	9.5%	16.0%	20.2%	48.4%	16.6%	18.7%	18.7%	20.7%
Other income	3	4	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	4	4	5	5	4	13	8	12
Interest	6	7	9	9	12	14	17	8	12	11	19	14	14	12	18	19	23	16	21	22	27	24	32	27	31	30	32	28	31	28	31	26	26	24	32	24	23	22	20	21	19	17	28	5	22	22	35
Depreciation	4	4	4	5	5	6	11	9	9	8	10	10	8	9	11	14	12	11	3	12	12	14	16	15	17	18	16	18	17	17	33	21	21	21	21	22	22	22	22	22	21	22	21	25	25	25	28
Profit before tax	10	9	13	12	12	10	15	13	14	15	13	16	20	33	16	20	24	30	8	-43	-39	-12	-25	-8	-9	-14	-113	-17	-19	-12	-95	-16	-16	-17	-34	-17	-14	-9	-16	-23	-7	0	59	28	2	42	-3
Tax	2	2	1	2	2	2	4	2	2	2	-8	1	-1	8	-11	3	2	1	-10	0	0	0	-1	0	-0	0	-20	0	-0	0	-24	0	0	0	-24	0	0	0	-16	0	0	0	11	0	0	0	20
Net profit	7	7	11	10	10	8	11	11	12	13	21	15	22	25	26	17	22	28	18	-43	-39	-12	-24	-8	-9	-14	-93	-17	-19	-12	-71	-16	-16	-17	-10	-17	-14	-9	0	-23	-7	0	48	28	2	42	-23
EPS ₹	3.15	3.17	4.88	4.17	4.26	3.42	4.35	4.44	4.51	4.83	7.68	5.24	7.42	8.34	8.96	5.05	6.43	8.06	5.12	-11.11	-10.06	-3.07	-6.18	-2.01	-2.18	-3.45	-22.12	-4.18	-4.58	-3.02	-17.31	-3.98	-3.83	-4.23	-2.33	-4.08	-3.52	-2.02	0.10	-5.13	-1.65	0.02	10.63	6.08	0.34	9.09	-4.89
Revenue YoY	—	—	—	—	35.1%	34.9%	20.5%	21.9%	33.9%	41.4%	34.9%	17.5%	8.3%	43.0%	52.7%	39.7%	66.1%	15.7%	18.2%	9.2%	-5.0%	-34.5%	-37.7%	-17.0%	-29.1%	6.1%	-4.9%	-25.5%	-31.9%	-36.3%	-25.8%	-8.1%	1.1%	-2.8%	1.9%	3.3%	3.9%	13.0%	6.5%	-8.3%	8.5%	-4.8%	25.9%	8.9%	-14.6%	18.0%	-11.3%
Profit YoY	—	—	—	—	45.1%	17.0%	-3.8%	12.1%	19.6%	59.0%	91.8%	31.9%	73.9%	83.0%	27.2%	16.7%	2.6%	15.5%	-30.4%	-349.9%	-276.6%	-142.3%	-232.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	11041.9%	—	—	60271.4%	-148.5%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 23 periods

	MAR '20	JUN '20	SEP '20	DEC '20	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	-0.0%	1.7%	10.7%	7.7%	3.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.6%	1.3%	1.3%	1.3%	3.0%
ROCE	—	—	—	—	—	—	7.0%	7.5%	11.6%	12.2%	12.9%	12.8%	54.7%	49.3%	39.8%	35.3%	16.9%	17.7%	17.0%	18.4%	3.6%	5.2%	7.0%
Net margin	-0.7%	-0.1%	1.1%	3.4%	-2.0%	-0.1%	-0.0%	0.9%	6.0%	4.3%	2.3%	0.0%	0.0%	0.0%	0.1%	0.1%	0.2%	0.1%	1.8%	2.9%	2.8%	2.6%	5.8%
EBITDA margin	16.7%	17.7%	19.6%	20.7%	18.9%	18.5%	17.6%	16.7%	19.1%	19.2%	20.1%	20.3%	10.9%	7.0%	-1.0%	-16.4%	-23.6%	-10.2%	-4.1%	0.0%	4.8%	9.0%	13.8%
Debt / equity	—	—	—	—	—	—	1.42	1.42	1.26	1.26	1.10	1.10	0.02	0.02	0.02	0.02	0.03	0.03	0.02	0.02	0.01	0.01	0.01
Interest coverage	0.68	0.86	1.10	1.31	1.13	1.14	1.15	1.25	1.95	2.12	2.31	2.32	10.15	15.14	40.24	-33.68	-7.86	-8.58	-9.65	-10.67	36.03	75.22	373.46
Asset turnover	—	—	—	—	—	—	0.63	0.67	0.66	0.68	0.68	0.66	1.10	0.86	0.61	0.38	0.13	0.22	0.29	0.38	0.37	0.40	0.42

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	60	60	60	59	59	69	82	87	87
Other equity / reserves	586	622	671	872	952	1,104	1,226	1,297	1,387
Total equity	646	682	730	931	1,012	1,173	1,308	1,384	1,474
Borrowings	916	862	801	17	16	41	22	18	20
Current liabilities	342	371	322	221	164	221	210	255	262
Non-current liabilities	829	771	747	12	12	45	27	35	35
Total assets	1,817	1,824	1,799	1,165	1,188	1,438	1,544	1,673	1,771
Property, plant & equipment	597	583	566	5	5	260	270	275	274
Capital work-in-progress	14	8	8	—	0	—	0	10	40
Investments	30	30	30	111	192	213	312	248	281
Inventories	454	439	441	10	9	114	109	148	170
Receivables	498	505	514	169	58	165	175	199	245
Cash & equivalents	14	18	13	432	438	428	400	430	340

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	150	195	-181	-25	-63
Cash from investing	5	-13	-104	-110	-73
Cash from financing	-141	-186	699	69	142
Capex	18	13	45	64	88
Free cash flow	132	182	-225	-90	-151
Dividends paid	0	0	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹274 cr15%

CWIP

₹40 cr2%

Investments

₹281 cr16%

Inventories

₹170 cr10%

Receivables

₹245 cr14%

Cash & equivalents

₹340 cr19%

Other assets

₹421 cr24%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Ind-Swift Laboratories Limited	3,028	348.20	69.2	2.05	3.0%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-11.0%

6 months+149.2%

1 year+238.0%

3Y CAGR+56.7%

5Y CAGR+36.6%

10Y CAGR+23.8%

50-day avg₹372.73

200-day avg₹221.56

RSI (14)48

FAQs

What is the share price of Ind-Swift Laboratories Limited?

Ind-Swift Laboratories Limited (INDSWFTLAB) closed at ₹348.20 on NSE on 06 Nov 2026.

What is the market cap of Ind-Swift Laboratories Limited?

₹3,028 crore at the latest close.

What is the P/E ratio of Ind-Swift Laboratories Limited?

69.2, on trailing-twelve-month earnings from its filings.

How fast is Ind-Swift Laboratories Limited growing?

Ind-Swift Laboratories Limited: revenue has compounded at -19.0% a year over three years. Latest-quarter revenue is up 57.5% year on year, profit up 328.3%.

How profitable is Ind-Swift Laboratories Limited?

On a trailing-twelve-month basis return on equity is 3.0%, return on capital employed 7.0%, operating margin 13.8%, net margin 5.8%.

How much debt does Ind-Swift Laboratories Limited have?

Ind-Swift Laboratories Limited is debt-free: debt to equity is 0.01 with borrowings of ₹20 cr against cash of ₹340 cr (balance sheet of 2026-09-30). Operating profit covers interest 373.5 times.

Financials parsed from Ind-Swift Laboratories Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.